Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Genset and Sanofi-Synthelabo enter CNS-related pharmacogenomics collaboration

April 19, 2000

Genetronics expands electroporation collaborations for gene therapy

April 19, 2000

Atrix to be issued broader U.S. patent for BEMA technology

April 18, 2000

Vertex enters genomic and proteomic alliance with Harvard

April 17, 2000

Protein Design Labs enters patent license agreement with Merck KGaA

April 17, 2000

Cambridge Discovery Chemistry moves forward in deal with AstraZeneca

April 13, 2000

Aradigm announces gene therapy research collaboration with UCSF

April 12, 2000

Magainin discovers additional aminosterols with therapeutic potential

April 12, 2000

Gemini Genomics and Kyowa Hakko discover novel gene for metabolic syndrome

April 11, 2000

Cannabinoid receptor affinity probes designed by U. of Connecticut scientists

April 10, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 5, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.